Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF–identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012–2017: A Retrospective Province-Wide Cohort Study

André N H Bulabula Jenna A Nelson Eric M Musafiri Rhoderick MachekanoNadia A Sam-Agudu Andreas H Diacon Maunank Shah Jacob Creswell Grant TheronRobin M Warren Karen R Jacobson Jean-Paul Chirambiza Dieudonné KalumunaBertin C Bisimwa Patrick D M C Katoto Michel K Kaswa Freddy M BirembanoLiliane Kitete Martin P Grobusch Zacharie M Kashongwe Jean B Nachega 13 February 2019 - Clinical Infectious Diseases